Corporate Board Profile
Tech Score: 100/100
1 mention(s) identify DANIEL R. OMSTEAD, ENG.SCD as having software/technology expertise.
Company | Filing Date | Evidence | Reason |
---|---|---|---|
abrdn Healthcare Investors | 2003-05-12 | Trustee (since 2003) of HQH and of HQL; President (since 2001) of HQH and HQL; President and Chief Executive Officer (since 2001) and Managing Director (since 2000) of the Adviser; formerly President and Chief Executive Officer (from 1997-2000) and Chief Operating Officer (1997) of Reprogenesis, Inc. | Has an engineering doctorate and was President and CEO of Reprogenesis, Inc., indicating technical and software-related expertise. |
Filing Date | Source Excerpt |
---|---|
2003-05-12 | Trustee (since 2003) of HQH and of HQL; President (since 2001) of HQH and HQL; President and Chief Executive Officer (since 2001) and Managing Director (since 2000) of the Adviser; formerly President and Chief Executive Officer (from 1997-2000) and Chief Operating Officer (1997) of Reprogenesis, Inc. |
Data sourced from SEC filings. Last updated: 2025-07-01